16
total announcements
541304.BO · 15 min delayed
Indo Us Bio-Tech Ltd
Indo Us Bio-Tech Ltd has published unaudited financial results for the quarter ended on 30-09-2026.
Indo Us Bio-Tech Ltd
Indo Us Bio-Tech Ltd has announced unaudited financial results for the quarter ended September 30, 2026, with the Board of Directors approving the results and limited review reports obtained from the Auditor.
Indo Us Bio-Tech Ltd
Indo Us Bio-Tech Ltd has announced its unaudited financial results for the quarter ended 30th September 2026, along with a limited review report from its auditor. The Board of Directors has approved the financial results, which have been prepared in accordance with Ind-AS 34 -Interim Financial Reporting.
Indo Us Bio-Tech Ltd
Indo Us Bio-Tech Ltd has scheduled a Board meeting on 30th October 2026 to consider and approve the un-audited standalone financial results for the quarter and half year ended 30th September 2026.
Indo Us Bio-Tech Ltd
Indo Us Bio-Tech Ltd's directors and promoters, including Mr. Jagdish Ajudia, Mrs. Priyanka Samarth Patel, and Mr. Samarth Patel, have received an invitation to attend the 140th China Import and Export Fair (Canton Fair) in Guangzhou, China.
Indo Us Bio-Tech Ltd
Indo Us Bio-Tech Ltd received a certificate under Regulation 74(5) of SEBI (DP) Regulations, 2018.
Indo Us Bio-Tech Ltd
Indo Us Bio-Tech Ltd has announced the voting results of its 22nd Annual General Meeting (AGM) held on September 30, 2026. The meeting was conducted through remote e-voting and video conferencing, with 17 shareholders attending. The company has provided the details of voting results for each resolution in Annexure I.
Indo Us Bio-Tech Ltd
Indo Us Bio-Tech Ltd held its 22nd Annual General Meeting on September 30, 2026, through video conferencing. The meeting approved various resolutions, including the audited balance sheet, appointment of a director, and borrowing limits. The company also provided e-voting facilities to its members.
Indo Us Bio-Tech Ltd
Indo Us Bio-Tech Ltd has announced the closure of its trading window for all designated persons from October 1, 2026, until 48 hours after the unaudited financial results for the quarter and half year ending September 30, 2026, are announced to the stock exchanges.
Indo Us Bio-Tech Ltd
Indo Us Bio-Tech Ltd has announced the notice of its 22nd Annual General Meeting (AGM) to be held on September 30, 2026, through video conferencing or other digital means, as published in a newspaper.
Indo Us Bio-Tech Ltd
Indo Us Bio-Tech Ltd has announced the submission of a newspaper advertisement for its unaudited quarterly standalone financial results for the quarter ended June 30, 2026, as required by SEBI LODR Regulations.
Indo Us Bio-Tech Ltd
Indo Us Bio-Tech Ltd has announced its financial results for the quarter ended June 30, 2026, with a net profit of ₹307.70, up from ₹237.82 in the previous quarter. The company's total comprehensive income is ₹303.74, and its equity share capital is ₹2,005.20. The financial results were approved by the Board of Directors and reviewed by the Statutory Auditors.
Indo Us Bio-Tech Ltd
Indo Us Bio-Tech Ltd has announced the outcome of its board meeting held on August 12, 2026, where the board approved unaudited financial results for the quarter ended June 30, 2026, along with limited review reports from the auditor.
Indo Us Bio-Tech Ltd
Indo Us Bio-Tech Ltd has announced the outcome of its postal ballot, where shareholders voted on certain resolutions through remote e-voting. The voting results have been declared, and the outcome will be communicated to the stock exchanges and other stakeholders.
Indo Us Bio-Tech Ltd
Indo Us Bio-Tech Ltd has announced the results of its postal ballot, where shareholders have passed two resolutions: the regularization of the appointment of Mrs. Hemanshi Darsh Soni as an additional director and the appointment of M/s. Bhagat & Associates as the statutory auditor. The voting period commenced on July 5, 2026, and concluded on August 3, 2026. The resolutions were passed with 100% and 99.9983% of the votes, respectively.
Indo Us Bio-Tech Ltd
Indo Us Bio-Tech Ltd has scheduled a Board meeting on 12th August 2026 to consider unaudited financial results for the quarter ended 30th June 2026 and other corporate matters.